Newsmeme!
Discover News you didn't know existed
Incontinence
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Prostate Cancer Treatment Expert Dr. David B. Samadi, MD Responds To Cancer Institute Of New Jersey Study
Published March 19, 2010, 3:31 am, Medical News Today
According to a new study, who you see for prostate cancer heavily determines the treatment you will receive. The study, released by The Cancer Institute of New Jersey in New Brunswick and published in the Archives of Internal Medicine, claims that while most prostate cancer treatment options differ in many aspects, the majority of options are similar across the board. It suggested that the ...
Geriatrician shortage likely
Published March 18, 2010, 6:11 pm, Omaha World-Herald
The field is not as financially rewarding as others in medicine.
Debbie Purdy: I suck the marrow out of life, I'm not ready to die
Published March 18, 2010, 3:58 pm, Times Online
In a wallet on her kitchen table Debbie Purdy keeps the two pieces of plastic that will enable her to make her final journey.
Utility And Health-Related Quality Of Life In Prostate Cancer Patients 12 Months After Radical Prostatectomy Or ...
Published March 18, 2010, 8:48 am, Medical News Today
UroToday.com - The most common curative treatments for localized prostate cancer (PC), radical prostatectomy (RP) and radiation therapy (RT), have significant effects on quality of life. Most studies measured quality of life using psychometric instruments. Another approach uses the concept of utility. Utility is a global measure, scaled between 0 (dead) and 1 (full health), which reflects not ...
Community Calendar
Published March 18, 2010, 4:12 am, Deerfield Review
Deadline for items for the Community Calendar is Wednesday noon two weeks before desired publication date. Send information on fund-raisers, clubs, lectures, community events, reunions and support groups to Community Calendar, Pioneer Press, 3701 W. Lake, Glenview IL 60026; Fax (847) 486-7495; or e-mail to jmolitor@pioneerlocal.com. There is no charge for publication.
Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD
Published March 18, 2010, 1:43 am, News-Medical-Net
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically ...
NIST and HHS to develop software tools to support health IT testing infrastructure
Published March 17, 2010, 11:58 pm, News-Medical-Net
Fully incorporating modern information technology into the healthcare system promises many benefits, including better quality care, less paperwork and fewer medical errors while reducing unnecessary costs. In any such critical application, however, it's important to ensure that the new technology behaves as expected.
Local jury awards plaintiffs more than $700K against area doctor in lawsuit
Published March 17, 2010, 9:28 pm, The Daily & Sunday Review
A Bradford County jury found against a Towanda physician recently in a civil lawsuit, awarding the plaintiffs $724,932.According to information filed in the Bradford County Prothonotary's office, on March 8, following a trial, the jury found in favor of
HEALTH AND WELLNESS EXPO AT CAESIA GARDENS
Published March 17, 2010, 4:26 pm, Leader Community Newspapers
Over 55’s are invited to embrace a life of health and wellness at Caesia Gardens Retirement Village in the heart of Caroline Springs.
MediciNova Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate to Severe COPD ...
Published March 17, 2010, 1:30 pm, GlobeNewswire via Yahoo! Finance
SAN DIEGO -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange , today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease .
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |